XOMA Corporation (XOMA)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XOMA Royalty Corporation - XOMA
Ultragenyx Pharmaceutical Inc (RARE)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ultragenyx Pharmaceutical Inc. - RARE
Air Products and Chemicals Inc (APD)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Air Products and Chemicals, Inc. - APD
Outset Medical Inc. (OM)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Outset Medical, Inc. - OM
Quest Diagnostics Incorporated (DGX)
Quest Diagnostics to Release Fourth Quarter and Full Year 2025 Financial Results on February 10, 2026
Rezolute Inc. (RZLT)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rezolute, Inc. - RZLT
China SXT Pharmaceuticals Inc. (SXTC)
CHINA SXT PHARMACEUTICALS, INC. ANNOUNCES STRATEGIC AI INSIGHTS INITIATIVE TO OPTIMIZE TRADITIONAL CHINESE MEDICINE PORTFOLIO, ENHANCE MARKET ANALYSIS AND EXPLORE AI-SUPPORTED CLINIC DEPLOYMENT
VolitionRX Limited (VNRX)
VolitionRx Secures $2.0 Million in Funding
Akari Therapeutics plc (AKTX)
Akari Therapeutics to Present at the 2026 Biotech Showcase
Genelux Corp (GNLX)
Genelux Corporation Announces Pricing of $20.0 Million Underwritten Public Offering of Common Stock